Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2000 Aug;15(Suppl 1):145–157. doi: 10.1007/BF02867554

Chromosomal fragility and human genetic disorders

Sujatha Baskaran 1, Vani Brahmachari 1,2,✉
PMCID: PMC3454080  PMID: 23105278

Abstract

The first report of X-linked mental retardation correlated with the presence of marker chromosome came in 1940. It was in 1990 that the molecular basis of fragile X syndrome was deciphered. This elucidation marked the discovery of a novel process of mutation designated as dynamic mutations, resulting in the expansion of a triplet repeat sequence within the human genome. Subsequently several human genetic disorders involving triplet repeat expansion have been discovered. Almost all the disorders are known to affect the nervous system and/or the brain. This review presents an overview of fragile sites in the genome and the molecular genetics of fragile X syndrome.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

References

  • 1.Sutherland G.R. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science. 1977;197:265–266. doi: 10.1126/science.877551. [DOI] [PubMed] [Google Scholar]
  • 2.Sutherland G.R. The detection of fragile sites on human chromosomes. In: Adolph K.W., editor. Advanced techniques in chromosome research. New York: Dekker; 1991. pp. 203–266. [Google Scholar]
  • 3.Sutherland G.R. In: Human fragile sites. In genetic maps. O'Brien J., editor. New York: Cold Spring Habour Laboratory Oress; 1993. pp. 6.264–6.267. [Google Scholar]
  • 4.Jones C., Penny L., Mattina T., Yu S., Baker E., Voullaire L., Langdon W.Y., Sutherland G.R., Richards R.I., Tunnacliffe A. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene 1CBL 2. Nature. 1995;376:145–149. doi: 10.1038/376145a0. [DOI] [PubMed] [Google Scholar]
  • 5.Nelson D.L. The fragile X mental retardation syndrome. In: Shaw Duncan J., editor. Molecular genetics of human inherited disease. Baffins, England: John Wiley and Sons Ltd; 1995. pp. 91–116. [Google Scholar]
  • 6.Brown W.T. The FRAXE syndrome: Is it time for routine screening? Amer. J. Hum. Gen. 1996;58:903–905. [PMC free article] [PubMed] [Google Scholar]
  • 7.Parrish J.E., Oostra B.A., Verkerk A.J.M.H., Richards S., Reynolds J., Spikes A.S., Shaffer L.G., Nelson D.L. Isolation of a GGC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet. 1994;8:229–235. doi: 10.1038/ng1194-229. [DOI] [PubMed] [Google Scholar]
  • 8.Howard Peebles P.N. Fragile X expression: Use of double induction system. Amer. J. Med. Genet. 1991;38:445–449. doi: 10.1002/ajmg.1320380261. [DOI] [PubMed] [Google Scholar]
  • 9.Penrose L.S. A clinical and genetic study of 1280 cases of mental defect. London: Medical Research Council; 1938. [Google Scholar]
  • 10.Martin J.P., Bell J.J. A pedigree of mental defects showing sex linkage. Neurol. Neurosurg. Psychiatry. 1943;6:154–157. doi: 10.1136/jnnp.6.3-4.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Escalante J.A., Grunspun H., Frosa-Pessoa O. Severe sex linked mental retardation. J. Hum. Genet. 1971;19:137–140. [Google Scholar]
  • 12.Lubs H.A. A marker X chromosome. Amer. J. Hum. Genet. 1969;21:231–244. [PMC free article] [PubMed] [Google Scholar]
  • 13.Brown, W.T. (1989) The fragile X syndrome. Neurologic Clinics 107–121 [PubMed]
  • 14.Fryns J.P. The fragile X syndrome: A study of 83 families. Clin. Genet. 1984;26:497–528. doi: 10.1111/j.1399-0004.1984.tb01099.x. [DOI] [PubMed] [Google Scholar]
  • 15.Hagerman R., Jackson A., Levitas A., Rimland B., Braden M. An analysis of autism in 50 males with fragile X syndrome. Amer. J. Med. Genet. 1986;23:359–374. doi: 10.1002/ajmg.1320230128. [DOI] [PubMed] [Google Scholar]
  • 16.Gronskov K., Hjalgrim H., Bjerager M.O., Brondum-Nielsen K. Deletion of CGG repeats plus flanking sequences in FMR-1 does not abolish gene expression. Amer. J. Hum. Genet. 1997;61:961–967. doi: 10.1086/514872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tarleton J., Ritchie R., Schwartz C., Rao K., Aylsworth A.S., Lachiewicz A. An extensivede novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. Hum. Mol. Genet. 1993;2:1973–1974. doi: 10.1093/hmg/2.11.1973. [DOI] [PubMed] [Google Scholar]
  • 18.Gedeon A.K., Baker E., Robinson H., Partington M.W., Gross B., Manca A., Korn B., Poustka A., Yu S., Sutherland G.R., Mulley J.C. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat. Genet. 1992;1:341–344. doi: 10.1038/ng0892-341. [DOI] [PubMed] [Google Scholar]
  • 19.Lugenbeel K.A., Peier A.M., Carson N.L., Chudley A.E., Nelson D.L. Intragenic role of FMR1 in fragile X syndrome. Nat. Genet. 1995;10:483–485. doi: 10.1038/ng0895-483. [DOI] [PubMed] [Google Scholar]
  • 20.Boulle K., Verkerk A.J.M.K., Reyniers E., Vits L., Hendrikx J., Roy B., Bos F., Graaf E., Oostra B.A., Willems P.J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 1993;3:31–35. doi: 10.1038/ng0193-31. [DOI] [PubMed] [Google Scholar]
  • 21.Gecz J., Gedeon A.K., Sutherland G.R., Mulley J.C. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet. 1996;13:105–108. doi: 10.1038/ng0596-105. [DOI] [PubMed] [Google Scholar]
  • 22.Ashley C.T., Sutcliffe J.S., Kunst C.B., Leiner H.A., Eichler E.E., Nelson D.L., Warren S.T. FMR-1 protein: conserved RNP family family domains and selective RNA binding. Science. 1993;262:563–566. doi: 10.1126/science.7692601. [DOI] [PubMed] [Google Scholar]
  • 23.Khanjian E.W., Fortin A., Thibodeau A., Tremblay S., Cote F., Devy D., Mandel J.L., Rousseau F. A heterogeneous set of FMR 1 protein is widely distributed in mouse tissues and ic modulated in cell culture. Hum. Mol. Genet. 1995;4:738–790. doi: 10.1093/hmg/4.5.783. [DOI] [PubMed] [Google Scholar]
  • 24.Abitbol M., Menini C., Delezoide A-L., Rhyner T., Vekemans M., Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet. 1993;4:147–152. doi: 10.1038/ng0693-147. [DOI] [PubMed] [Google Scholar]
  • 25.Bachner D., Manca A., Steinbach P., Wohrle D., Just W., Vogel W., Horst H., Poustka A. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the maleand the female gonad. Hum. Mol. Genet. 1993;12:2043–2050. doi: 10.1093/hmg/2.12.2043. [DOI] [PubMed] [Google Scholar]
  • 26.Hergersberg M., Matsuo K., Gassmann M., Schaffner W., Luscher B., Rulicke T., Aguzzi A. Tissue specific expression of a FMR-1/b-galactosidase fusion gene in transgenic mice. Hum. Mol. Genet. 1995;4:359–366. doi: 10.1093/hmg/4.3.359. [DOI] [PubMed] [Google Scholar]
  • 27.Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., Warren S.T. Translational suppression by trinucleotide repeat expansion at FMR1. Science. 1995;268:731–734. doi: 10.1126/science.7732383. [DOI] [PubMed] [Google Scholar]
  • 28.Zhang Y., O'Connor P.J., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXP2. EMBO. 1995;14:5358–5366. doi: 10.1002/j.1460-2075.1995.tb00220.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Eberhart D.E., Malter H.E., Feng Y., Warren S.T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 1996;5:1083–1091. doi: 10.1093/hmg/5.8.1083. [DOI] [PubMed] [Google Scholar]
  • 30.Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., Warren S.T. FMRP associates with polyribosomes as an mRNP and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1997;1:109–118. doi: 10.1016/S1097-2765(00)80012-X. [DOI] [PubMed] [Google Scholar]
  • 31.Fridell R.A., Benson E.R., Hua J., Bogerd H.P., Cullen B.R. A nuclear role for the fragile X mental retardation protein. EMBO. 1996;15:5408–5414. [PMC free article] [PubMed] [Google Scholar]
  • 32.Sherman S.L., Morton N.E., Jacobs P.A., Turner G. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann. Hum. Genet. 1984;48:21–37. doi: 10.1111/j.1469-1809.1984.tb00830.x. [DOI] [PubMed] [Google Scholar]
  • 33.Sutherland G.R., Richards R.I. Simple tandem DNA repeats and human genetic disease. Proc. Natl. Acad. Sci. USA. 1995;92:3636–3641. doi: 10.1073/pnas.92.9.3636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Laird C.D. Possible erasure of the imprint on a fragile X chromosome when transmitted by a male. Amer. J. Med. Genet. 1991;38:391–395. doi: 10.1002/ajmg.1320380247. [DOI] [PubMed] [Google Scholar]
  • 35.Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971;11:971–972. doi: 10.1016/S0140-6736(71)90287-X. [DOI] [PubMed] [Google Scholar]
  • 36.Chetan G.K. Systematic survey of the frequency of fragile X chromosome among subjects with non-specific mental retardation: A prospective study. Bangalore: National Institute of Mental Health and Neuro Sciences (Deemed University); 1996. [Google Scholar]
  • 37.Rousseau F., Heitz D., Biancalana V., Blumnenfeld S., Kretz C., Boue' J., Tommerup N., Gilgenkrantz S., Jalbert P., Voelckel M-A., Oberle' I., Mandel J.L. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New Engl. J. Med. 1991;325:1673–1681. doi: 10.1056/NEJM199112123252401. [DOI] [PubMed] [Google Scholar]
  • 38.Sujatha B., Naseerullah M.K., Manjunatha K.R., Chetthan G.K., Arthi R., Bhaskar G.V., Girmaji S.R., Shobha S., Sheshadri S., Radha R.D., Vani B. Triplet repeat polymorphism and fragile X syndrom in the Indian context. Ind. J. Med. Res. 1998;107:29–36. [PubMed] [Google Scholar]
  • 39.Willemsen R., Los F., Mohkamsing S., Oue A., Deelen W., Galjard H., Oostra B. Rapid antibody test for prenatal diagnosis of fragile X syndrome in amniotic fluid cells: a new upraisal. J. Med. Genet. 1997;34:250–251. doi: 10.1136/jmg.34.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Eichler E.E., Hammond H.A., Macpherson J.N., Ward P.A., Nelson D.L. Population survey of the human FMR1 CGG repeat substructure suggests biased polarity for the loss of AGG interruptions. Hum. Mol. Genet. 1995;4:2199–2208. doi: 10.1093/hmg/4.12.2199. [DOI] [PubMed] [Google Scholar]
  • 41.Sujatha B. A mouse model for dynamic mutation and fragile syndrome. Bangalore, India: Indian Institute of Science; 2000. [Google Scholar]
  • 42.Bakker C.E., Verheij C., Willemsen R., Vamnderhelm R., Oerlemans F., Vermey M., Bygrave A., Hoogeveen A.T., Oostra B.A., Reyniers E., Deboulle K., Dhooge R., Cras P., Velzen D., Nagels G., Martin J.J., Dedeyn P.P., Darby J.K., Willems P.J.Fmr-1 knock-out mice: a model to study fragile X mental retardation Cell 19947823–33.8033209 [Google Scholar]
  • 43.Lavedan C.N., Garrett L., Nussbaum R.L. Trinucleotide repeats (CGG)22TGG(CGG)43TGG. (CGG)21 from the fragile X gene remain stable in transgenic mice. Hum. Genet. 1997;100:407–414. doi: 10.1007/s004390050525. [DOI] [PubMed] [Google Scholar]
  • 44.Bontekoe C.J., Graaf E., Nieuwenhuizen I.M., Willemsen R., Oostra B.A. FMR-1 premutation allele is stable in mice. Eur. J. Hum. Genet. 1997;5:293–298. [PubMed] [Google Scholar]
  • 45.Kruyer H., Mila M., Glover G., Carbonell P., Ballesta F., Estivill X. Fragile X syndrome and the (CGG)n mutation: Two families with discordant monozygotic twins. Am. J. Hum. Genet. 1994;54:437–442. [PMC free article] [PubMed] [Google Scholar]
  • 46.Malter H.E., Iber J.C., Willemsen R., Graaff E., Tarleton J.C., Leisti J., Warren S.T., Oostra B.A. Characterisation of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 1997;15:165–169. doi: 10.1038/ng0297-165. [DOI] [PubMed] [Google Scholar]
  • 47.Snow K., Tester D.J., Kruckeberg K.E., Schaid D.J., Thibodeau S.N. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum. Mol. Genet. 1994;3:1543–1551. doi: 10.1093/hmg/3.9.1543. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES